Core Viewpoint - Novartis is set to acquire Tourmaline Bio for $48.00 per share, totaling approximately $1.4 billion, reflecting a significant premium over Tourmaline's recent stock prices, indicating strong confidence in Tourmaline's lead asset, pacibekitug, for treating cardiovascular diseases [1][2][3]. Transaction Details - The acquisition will be executed through a tender offer for all outstanding shares of Tourmaline at $48.00 per share in cash, representing a 59% premium to the closing stock price on September 8, 2025, and a 127% premium to the 60-day volume-weighted average stock price [1][3]. - The transaction has received unanimous approval from the Boards of Directors of both Novartis and Tourmaline and is expected to close in the fourth quarter of 2025, pending customary closing conditions [1][4]. Company Insights - Tourmaline Bio is a late-stage clinical biotechnology company focused on developing transformative medicines for inflammatory and immune diseases, with pacibekitug as its lead asset [6][7]. - Pacibekitug is a long-acting, fully-human, anti-IL-6 monoclonal antibody with potential best-in-class properties, having been studied in approximately 450 participants across six clinical trials [5][6]. Strategic Implications - The acquisition aligns with Novartis's commitment to innovation in cardiovascular care, as pacibekitug targets inflammation, a key driver of cardiovascular diseases, and addresses a significant unmet medical need in anti-inflammatory therapies [2][5]. - Novartis aims to leverage Tourmaline's expertise and accelerate the development of pacibekitug, enhancing its portfolio in cardiovascular treatment [2][4].

EfTEN Real Estate Fund AS earned consolidated rental income of EUR 2,704 thousand in August 2025, which is EUR 15 thousand more than in July. The increase in rental income was primarily due to the commencement of rental income of the new wing of the Ermi care home. The fund’s consolidated net rental income (NOI) in August amounted to EUR 2,622 thousand, up by EUR 18 thousand compared to July. During the first eight months of 2025, the fund earned total consolidated rental income of EUR 20.97 million, which ...

MIAMI, Sept. 09, 2025 (GLOBE NEWSWIRE) -- NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”), announced today that it has priced $1,300.0 million aggregate principal amount of its 0.750% exchangeable senior notes due 2030 (the “Exchangeable Notes”), which were offered in a private offering (the “Exchangeable Notes Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The aggregate p ...

Core Viewpoint - Norwegian Cruise Line Holdings Ltd. has announced a registered direct offering of 3,313,868 ordinary shares priced at $24.53 per share to certain holders of its subsidiary's exchangeable senior notes, aimed at repurchasing a significant amount of these notes [1][2]. Group 1: Equity Offering Details - The Equity Offering is expected to close on September 11, 2025, subject to customary closing conditions [2]. - The net proceeds from the Equity Offering, along with proceeds from a separate offering of exchangeable senior notes, will be used to repurchase approximately $958.0 million of 1.125% Exchangeable Senior Notes and approximately $449.0 million of 2.50% Exchangeable Senior Notes [2]. Group 2: Repurchase Impact - After the repurchase, approximately $192.0 million of the 1.125% Exchangeable Senior Notes and approximately $24.2 million of the 2.50% Exchangeable Senior Notes will remain outstanding [3]. - The Transactions are expected to be neutral to the Company's leverage and will reduce the Company's shares outstanding on a fully diluted basis by approximately 38.1 million shares [3]. Group 3: Placement Agent and Regulatory Compliance - J.P. Morgan Securities LLC is acting as the exclusive placement agent for the Equity Offering [4]. - The offering is being made under an automatic shelf registration statement filed with the U.S. Securities and Exchange Commission, with a preliminary prospectus supplement already filed [4].

Core Viewpoint - Wix.com Ltd. has announced the pricing of $1.0 billion aggregate principal amount of 0.00% Convertible Senior Notes due 2030, increasing from the previously announced $750 million offering, with a potential additional $150 million option for initial purchasers [1][10] Group 1: Offering Details - The Notes will not bear regular interest and will mature on September 15, 2030, unless repurchased, redeemed, or converted earlier [2] - Wix may redeem the Notes under specific conditions, including tax-related events and if the share price meets certain thresholds [3] - Holders of the Notes can require Wix to repurchase their Notes upon a fundamental change at a cash purchase price of 100% of their principal amount plus any accrued interest [4] Group 2: Conversion and Pricing - The initial conversion rate is set at 4.7509 ordinary shares per $1,000 principal amount of Notes, equating to an initial conversion price of approximately $210.49 per share, representing a 37.5% premium to the last reported sale price [5] - The conversion of the Notes will be settled in cash, ordinary shares, or a combination thereof, at Wix's discretion [5] Group 3: Financial Implications - Wix estimates net proceeds from the Offering to be approximately $977.3 million, intended for capped call transactions, share repurchases, and general corporate purposes [10] - Approximately $75 million of the net proceeds will be used for the concurrent repurchase of about 0.49 million ordinary shares at a price of $153.08 per share [11] Group 4: Capped Call Transactions - Wix has entered into capped call transactions to cover the number of ordinary shares underlying the Notes, which may reduce potential dilution upon conversion [7] - The cap price for these transactions is set at $267.89 per share, a 75% premium over the last reported sale price of $153.08 [8] Group 5: Market Impact - The initial purchasers may engage in derivative transactions that could influence the market price of Wix's ordinary shares and the Notes [9]

Core Viewpoint - NCL Corporation Ltd. has announced the pricing of $1,200 million in 5.875% senior notes due 2031 and $850 million in 6.250% senior notes due 2033, as part of a private offering exempt from registration under the Securities Act [1][2] Group 1: Unsecured Notes Offering - The Unsecured Notes Offering is expected to close on September 17, 2025, subject to customary closing conditions [2] - The net proceeds from the Unsecured Notes Offering will be used to fund a concurrent tender offer for 5.875% senior notes due 2026 and 5.875% senior secured notes due 2027, redeem all 2026 and 2027 Notes not accepted in the tender offer, redeem all 8.125% senior secured notes due 2029, and pay accrued interest and related transaction costs [2] - The transactions will be essentially neutral to NCLC's leverage [2] Group 2: Offering Details - The Unsecured Notes are offered only to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S, and will not be registered under the Securities Act [3] - The offering does not constitute an offer to sell or a solicitation of an offer to buy any security [4] Group 3: Company Overview - Norwegian Cruise Line Holdings Ltd. operates Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, with a combined fleet of 34 ships and over 71,000 berths, offering itineraries to approximately 700 destinations worldwide [5] - The company plans to add 13 additional ships across its brands by 2036, which will increase its fleet capacity by over 38,400 berths [5]

Core Insights - Oliveda International, Inc. announced the launch of its Olive Rose brand featuring hydroxytyrosol NO MAKEUP at New York Fashion Week from September 12-15, 2025, marking a significant step in the company's product development strategy [1][2] - The Olive Rose collection includes a variety of beauty products that utilize hydroxytyrosol, emphasizing the company's commitment to innovative and holistic beauty solutions [5][6] Product Launch and Events - The Olive Rose brand will be showcased at New York Fashion Week, with 75 waterless beauty makeup artists providing over 150 models with the "Olive Rose Glow" look [2] - The entire Olive Rose collection will be presented to approximately 70,000 waterless beauty consultants in the U.S. and Canada at the North America Convention in Los Angeles on October 4, 2025, with training sessions planned before the products are available to customers in November [4] Product Details - The Olive Rose Hydroxytyrosol NO MAKEUP Collection features 14 shades of Hydroxytyrosol Skin Tint Serum, 8 Hydroxytyrosol Blushes, 4 Hydroxytyrosol Contour products, 16 shades of Hydroxytyrosol Concealer, Hydroxytyrosol Mascara, Hydroxytyrosol Eye Shadow, 2 Hydroxytyrosol Lip Butters, Hydroxytyrosol Primer, and Hydroxytyrosol Setting Spray [5] Company Background - Oliveda International, Inc. and its subsidiary, Olive Tree People Inc., have over 20 years of experience in organic certification and the production of cosmetic and holistic waterless products related to the olive tree [7] - The company is led by Thomas Lommel, who has developed unique products and concepts in the beauty and wellness industry, including the Olive Tree Therapy and olive matcha [7][8] Market Positioning - Waterless beauty is gaining recognition as a significant trend in the beauty industry, with endorsements from major publications and celebrities, positioning Oliveda as a key player in this emerging market [10]

Core Insights - Abaxx Technologies Inc. has appointed Russell Robertson as Chief Business Development Officer at Abaxx Exchange, effective September 9, 2025, to enhance commercial momentum and international growth initiatives [1][2][5] Company Overview - Abaxx Technologies is a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., which owns Abaxx Commodity Exchange and Clearinghouse [1][6] - The company aims to build Smarter Markets by providing better tools, benchmarks, and technology to address societal challenges, including the energy transition [5] Leadership Background - Russell Robertson has over 25 years of experience in global financial markets, previously serving as Chief Commercial Officer at Gulf Mercantile Exchange, where he led strategic investments and partnerships [2][3] - His prior roles include senior positions at CME Group and ICE Clear Europe, focusing on product development and clearing technology [4] Market Infrastructure - Abaxx Exchange provides critical market infrastructure for the transition to a low-carbon economy, offering centrally-cleared, physically-deliverable futures contracts in LNG, carbon, battery materials, and precious metals [7] - Abaxx Spot modernizes physical gold trading through a physically-backed gold pool in Singapore, enabling secure electronic transactions and supporting physical delivery for gold futures contracts [8] Additional Services - Adaptive Infrastructure addresses gaps in post-trade infrastructure by offering custodial services across environmental markets and digital title assets, regulated by the Financial Services Commission of Barbados [9]

Core Points - Voxtur Analytics Corp. has been noted in default by the Canadian securities authority due to the failure to file its financial statements for Q2 2025 by the deadline [1] - A cease trade order (CTO) has been issued, prohibiting all trading of the company's securities in Canada until the required disclosures are filed and the order is revoked [2] - The company has until October 13, 2025, to post its Q2 financial statements to maintain its eligibility for the OTCQB listing; failure to do so will result in a downgrade to the OTC Pink market [3] - Voxtur has received a Notice of Default from its lender under the Credit Facility for multiple failures, including not providing financial statements and failing to maintain the required EBITDA ratio [4] Company Overview - Voxtur is a proptech company that provides targeted data analytics to streamline the real estate lending lifecycle for various market participants [5] - The company offers primary and secondary market solutions in the United States and Canada, focusing on enhancing transparency and accessibility in real estate lending [5]

HOUSTON, TX, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Talon Capital Corp. (the “Company”) announced the pricing of its initial public offering of 22,500,000 units at a price of $10.00 per unit on September 8, 2025. The units are expected to be listed for trading on the Nasdaq Stock Market LLC under the ticker symbol “TLNCU” beginning September 9, 2025. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase ...